Press release
Dasatinib Drugs Market Growth Accelerates: Strategic Forecast Predicts $1.95 Billion by 2029
Dasatinib Drugs
What Will the Dasatinib Drugs Industry Market Size Be by 2025?
The market for dasatinib drugs has experienced robust growth in recent years, projecting to escalate from $1.45 billion in 2024 to $1.53 billion in 2025. This equates to a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this unprecedented expansion during this historic period include the rising prevalence of chronic myeloid leukemia (CML), the progress made in targeted cancer therapies, the extensive research into tyrosine kinase inhibitors (TKIS), the surge in oncology research investment, and an increase in the number of clinical trials.
What's the Long-Term Growth Forecast for the Dasatinib Drugs Market Size Through 2029?
In the forthcoming years, a robust increase in growth is anticipated for the dasatinib drugs market, rising to "$1.95 billion in 2029 with a compound annual growth rate (CAGR) of 6.3%. This predicted surge during the forecast period is due to factors such as enhanced investments in oncological drug research, an increase in drug-resistant leukemia conditions, the expansion of generic dasatinib drugs, efforts towards reducing chemotherapy side effects, and heightened awareness and early detection of leukemia. Some of the significant trends forecasted for this period include the embrace of personalized medicine, the application of companion diagnostics, the creation of new formulations, progress in combination treatments, and the introduction of biosimilars.
View the full report here:
https://www.thebusinessresearchcompany.com/report/dasatinib-drugs-global-market-report
What Are the Key Growth Drivers Fueling the Dasatinib Drugs Market Expansion?
The rise in chronic myeloid leukemia (CML) cases is anticipated to boost the dasatinib drug market's expansion. This form of cancer, which affects bone marrow and blood, is marked by the abnormal proliferation of white blood cells. Factors such as lifestyle demographics, poor diet, and increasing environmental risks are contributing to a surge in CML prevalence. Dasatinib drugs, which inhibit BCR-ABL (a gene fusion) activity, prove useful in treating CML. This tyrosine kinase protein, generated by the Philadelphia chromosome mutation, stimulates unregulated growth of cancerous white blood cells. For instance, data from the American Cancer Society (ACS), a US-based health organization committed to eradicating cancer, shows an increase in CML cases in the United States - going from 8,860 in 2022 to 8,930 in January 2023. Consequently, the escalating occurrence of chronic myeloid leukemia (CML) is fueling growth in the dasatinib drug market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19023&type=smp
What Long-Term Trends Will Define the Future of the Dasatinib Drugs Market?
Prominent corporations in the dasatinib drugs market are concentrating on the production of generic medications to grow their market presence, offer economical treatment alternatives, and enhance patient accessibility. Generic drugs in the dasatinib sector provide more budget-friendly treatment possibilities, improving patient accessibility, fostering competition, and reducing healthcare expenses. For example, Apotex Corp., a Canadian pharmaceutical firm, in September 2024, introduced the first generic version of Sprycel dasatinib in the United States to treat specific leukemias in adults and children. This cost-effective solution enhances the availability of high-quality treatment choices. This groundbreaking move represents a crucial stride in escalating competition and decreasing prices in the dasatinib market.
How Is the Dasatinib Drugs Market Segmented?
The dasatinib drugs market covered in this report is segmented -
1) By Product Type: Tablets, Oral Suspension, Other Products
2) By Indication: Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Other Indications
3) By End User: Hospitals, Specialty Clinics, Home Healthcare
Subsegments:
1) By Tablets: 20 mg Tablets, 50 mg Tablets, 70 mg Tablets, 80 mg Tablets
2) By Oral Suspension: 20 mg Or 5 mL Oral Suspension, 40 mg Or 5 mL Oral Suspension
3) By Other Products: Injectable Formulations, Combination Therapies, Generic Dasatinib Products
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19023&type=smp
Which Companies Are Leading the Charge in Dasatinib Drugs Market Innovation?
Major companies operating in the dasatinib drugs market are Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Sandoz Group AG, Hetero Drugs Limited, Sun Pharmaceutical Industries Limited, MSN Laboratories Pvt. Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Intas Pharmaceuticals Ltd., Cipla Limited, Hikma Pharmaceuticals plc, Lupin Limited, Zhejiang Hisun Pharmaceutical Co. Ltd., Biocon Limited, Alkem Laboratories Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Mylan N.V., Manus Aktteva Biopharma LLP
Which Regions Are Leading the Global Dasatinib Drugs Market in Revenue?
North America was the largest region in the dasatinib drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dasatinib drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19023
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Reach Out to Us
Speak With Our Expert:Saumya Sahay,
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267,
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dasatinib Drugs Market Growth Accelerates: Strategic Forecast Predicts $1.95 Billion by 2029 here
News-ID: 4183933 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Dasatinib
Rising Prevalence Of Chronic Myeloid Leukemia (CML) Fuels Growth Of Dasatinib Dr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Dasatinib Drugs Industry Market Size Be by 2025?
The market for dasatinib drugs has seen robust growth lately. It's projected that the market will expand from $1.45 billion in 2024 to $1.55 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. This growth…
Dasatinib Tablets Market Outlook and Future Projections for 2030
The dasatinib tablets market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the current…
Rising Prevalence Of Chronic Myeloid Leukemia (CML) Fuels Growth Of Dasatinib Dr …
What industry-specific factors are fueling the growth of the dasatinib drugs market?
The growing incidence of chronic myeloid leukemia (CML) is anticipated to drive the expansion of the dasatinib drug market in the future. Chronic myeloid leukemia (CML) is a form of cancer that affects both the bone marrow and blood, characterized by the abnormal growth of white blood cells. The rising incidence of CML is primarily influenced by factors such…
Emerging Dasatinib Drugs Market Trend 2025-2034: Generic Dasatinib Boosting Comp …
How Is the Dasatinib Drugs Market Projected to Grow, and What Is Its Market Size?
There has been a robust expansion in the market size of dasatinib drugs in the past few years. The market is projected to escalate from a worth of $1.45 billion in 2024 to $1.55 billion in 2025 with a compound annual growth rate (CAGR) of 6.9%. The factors that have contributed to market growth during the…
Dasatinib Tablets Market Outlook and Future Projections for 2030
The dasatinib tablets market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the current…
Dasatinib Drugs Market to Grow Significantly by Leading Players 2023 to 2032
The competitive landscape analysis of Dasatinib Drugs Market uncovers detailed company profiles, revenue shares, portfolio innovations, regional product footprint, key developmental strategies, pricing structure, target markets, and near-term plans of market leaders. This entire section helps readers gain an essence of what is driving competition and what would help them stand out to win new target markets.
Market estimates and forecast are backed by an extensive primary research, further complemented by…
